Interesting- I would have said just the opposite. Such naive assertions that lab data will simply transfer to a human trial are a good reason to make people think twice about an investment here- at this time. Wait for the trial results, already- so you miss some of the big rise, if positive. At least you will not lose it all if the trial fails.
Just to repeat: B lab data as reported by all involved helped most to prevent spread of disease. Having see the patients admitted day after day after day, I can tell you something- almost everyone already has very widespread disease. It will not be an easy trial for B to ace.
One more thing- hey Leo? You gonna be wrong-again-about trial start timing? You have been wrong about so much.
Market Data 
Markets 
AI
